Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Names Abgenix CEO to Board of Directors

NEW YORK, June 4 – Illumina said Monday that R. Scott Greer, chairman and CEO of Abgenix, had been elected to its board of directors.

"We are honored that Scott has agreed to join our board. He brings a solid record of leadership and accomplishment in the life sciences industry and his insight and experience will be a tremendous asset to the company," said Jay Flatley, Illumina’s CEO, said in a statement.

Greer has been CEO of Abgenix since 1996. Prior to that he held senior positions with Cell Genesys. He has a bachelors in economics from Whitman College and an M.B.A. from Harvard University.

Greer will replace Charles Hartman, who did not stand for re-election.

Illumina of San Diego develops BeadArray technology to study genetic variation and function.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.